|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 47/20 | |||
| A61K 47/26 | |||
| A61K 9/00 | |||
| A61K 38/37 |
| (11) | Number of the document | 2385825 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09756369.6 |
| Date of filing the European patent application | 2009-11-06 | |
| (97) | Date of publication of the European application | 2011-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/063610 |
| Date | 2009-11-06 |
| (87) | Number | WO 2010/054238 |
| Date | 2010-05-14 |
| (30) | Number | Date | Country code |
| 112513 P | 2008-11-07 | US |
| (72) |
PIKAL, Michael, US
TCHESSALOV, Serguei, US
BJORNSON, Erik, US
JAMEEL, Feroz, US
BESMAN, Marc, US
|
| (73) |
Baxalta Incorporated,
1200 Lakeside Drive, Bannockburn, IL 60015,
US
University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, US Baxalta GmbH, Zaehlerweg 4, 6300 Zug, CH |
| (54) | FACTOR VIII FORMULATIONS |
| FACTOR VIII FORMULATIONS |